Navigation Links
Neogen Acquires International Diagnostic Systems
Date:5/4/2009

LANSING, Mich., May 4 /PRNewswire-FirstCall/ -- Neogen Corporation (Nasdaq: NEOG) has acquired International Diagnostic Systems Corp (IDS), a leading developer, manufacturer and marketer of test kits to detect drug residues in food and animal feed, and drugs in forensic and animal samples.

Based in St. Joseph, Mich., IDS has been in business for more than 20 years, and offers approximately 40 products. In addition to significant sales in the United States, IDS has distribution in France, Italy, Spain, Germany, and China. A key recent focus of the company has been the food safety market for testing animal feed, meat products, and seafood. IDS recorded revenues of approximately $2 million in its most recently completed fiscal year. Terms of the acquisition were not disclosed.

A part of IDS's operations will be relocated to and integrated with Neogen's Lexington, Ky., facilities. The company's research and development operations, and key IDS employees, will remain in IDS's Michigan facilities.

"We are pleased to have several valuable employees, with many years of experience at IDS, join Neogen," said Lon Bohannon, Neogen's president. "International Diagnostic's products are complementary and a nice fit with our existing forensic and drug detection product lines. The IDS purchase also provides Neogen with key collaborative relationships with influential industry partners, and increased access to important international markets, including China."

"We've had a long-standing respect for Neogen as both a competitor and a leader in supplying solutions for food and animal safety," said Deborah Morris, IDS's president. "We are pleased to be joining Neogen and helping to expand its markets."

IDS has been providing rapid immunoassay products for use in agriculture and veterinary markets since 1986. In the late 1980s, IDS began selling drug monitoring products to the horse and dog racing industry. In recent years, IDS expanded into the human forensics drug testing market.

Neogen Corporation develops and markets products dedicated to food and animal safety. The company's Food Safety Division markets dehydrated culture media, and diagnostic test kits to detect foodborne bacteria, natural toxins, genetic modifications, food allergens, drug residues, plant diseases and sanitation concerns. Neogen's Animal Safety Division markets a complete line of diagnostics, veterinary instruments, veterinary pharmaceuticals, nutritional supplements, disinfectants, and rodenticides.

Certain portions of this news release that do not relate to historical financial information constitute forward-looking statements. These forward-looking statements are subject to certain risks and uncertainties. Actual future results and trends may differ materially from historical results or those expected depending on a variety of factors listed in Management's Discussion and Analysis of Financial Condition and Results of Operations in the Company's most recently filed Form 10-K.


'/>"/>
SOURCE Neogen Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. NeoGenomics, Inc. Reports First Quarter 2009 Financial Results
2. NeoGenomics Schedules its Q1 2009 Earnings Release for April 23, 2009
3. NeoGenomics Appoints Douglas M. VanOort as Executive Chairman and Interim Chief Executive Officer
4. Neogen Reactivates Share Repurchase Program
5. NeoGenomics to Present at the Roth Capital Partners 21st Annual OC Growth Stock Conference
6. Webcast Alert: Neogen Corporation To Announce 2nd Quarter Results
7. NeoGenomics Schedules Its Q3 2008 Earnings Release for November 6, 2008
8. NeoGenomics to Present at the Noble Financial Equity Conference
9. NeoGenomics Announces Results for the Second Quarter of Fiscal Year 2008
10. NeoGenomics Announces Results for the 3rd Quarter 2007
11. NeoGenomics, Inc. Schedules its Q3 07 Earnings Conference Call For Wednesday, November 14, 2007 at 11:00 AM
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/16/2017)... Houston, TX (PRWEB) , ... August 16, 2017 , ... ... named as a Castle Connolly 2017 Top Doctor. The annual list identifies the nation’s ... row that Dr. Vitenas has made it to the top of Castle Connolly’s coveted ...
(Date:8/16/2017)... ... August 16, 2017 , ... SGNA Standards of Infection ... reprocessing cycle, both between patient procedures and before storage, is a requisite practice ... important to the prevention of disease transmission and nosocomial infection as cleaning and ...
(Date:8/16/2017)... ... August 16, 2017 , ... Richard Strawn’s new book ... the time of a cancer diagnosis, surgery and recovery, the Psalms provided encouragement ... many ways God shows love to those who are sick., Surgical Psalms contains ...
(Date:8/16/2017)... NJ (PRWEB) , ... August 16, 2017 , ... ... is offering an opportunity for men and women to train as hospice ... families dealing with life-limiting illness. For over 30 years, the agency has trained ...
(Date:8/16/2017)... ... 16, 2017 , ... Rollon Skin Care Ltd., ... recently announced the launch of two new skincare products, Prache Antiaging Cream and ... expensive plastic surgery or in-patient cosmetic dermatological procedures. , “Prache Antiaging Cream and ...
Breaking Medicine News(10 mins):
(Date:8/8/2017)... Second-quarter 2017 revenues of $876 million and ... operations Second-quarter 2017 Branded ... Second-quarter 2017 Sterile Injectables ... Second-quarter 2017 adjusted diluted earnings per ... $0.93 Second-quarter 2017 reported ...
(Date:8/7/2017)... Pharmacy, Inc. (NYSE: DPLO), the nation,s largest independent specialty pharmacy, ...  All comparisons, unless otherwise noted, are to the quarter ended ... Second Quarter 2017 Highlights include: Revenue ... 3.5% Total prescriptions dispensed of 220,000, compared ... 7.6% Gross profit per prescription dispensed ...
(Date:8/3/2017)... Aug. 3, 2017  Opioid addiction and other drugs ... healthcare costs and threatening outcomes, were problems taken on ... IVD industry that support them, met this week. This ... said that drugs of abuse, procalcitonin and acute kidney ... the organization,s 69th meeting in San Diego, ...
Breaking Medicine Technology: